Vertex Pharmaceuticals Inc. Stock
With only a change of -€0.060 (-0.030%) the Vertex Pharmaceuticals Inc. price is nearly unchanged from yesterday.
We see a rather positive sentiment for Vertex Pharmaceuticals Inc. with 9 Buy predictions and 1 Sell predictions.
With a target price of €260.00 there is a positive potential of 42.232% for Vertex Pharmaceuticals Inc. compared to the current price of €182.80.
So far the community has only identified positive things for Vertex Pharmaceuticals Inc. stock. The most positive votes were given for criterium "Revenue growth".
Pros and Cons of Vertex Pharmaceuticals Inc. in the next few years
Pros
1
Revenue growth >5% per year expected
1
EBIT growth >5% per year expected
1
Could be very worthwhile Investment >20% year
Cons
0
-
Performance of Vertex Pharmaceuticals Inc. vs. its peers
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -0.030% | 1.229% | 1.039% | -27.364% | -4.412% | 40.965% | 144.139% |
| IQVIA Holdings Inc. | 1.110% | 3.946% | 14.936% | 52.924% | 25.313% | - | - |
| Amgen Inc. | 0.490% | 3.038% | 4.538% | -1.147% | 15.994% | 54.154% | 49.459% |
| Regeneron Pharmaceuticals Inc. | -0.110% | 5.100% | 4.956% | -19.880% | 6.448% | 63.489% | 18.444% |
Comments
Other discussions about Vertex Pharmaceuticals Inc. Stock
Trading Vertex Pharmaceuticals Inc.
Trading Vertex Pharmaceuticals Inc.
